Haleon PLC Sponsored ADR (HLN) has released an update.
Haleon PLC reports a solid start to 2024 with a 3.0% organic revenue growth and a significant 12.8% organic operating profit growth, despite a 2.2% reported revenue decline influenced by foreign exchange and M&A activities. The company has seen strong performances in Oral Health and Vitamins, Minerals, and Supplements (VMS), attributing success to innovation and effective market execution. Haleon reaffirms its full-year guidance, projecting organic revenue growth of 4-6% and operating profit growth surpassing revenue growth.
For further insights into HLN stock, check out TipRanks’ Stock Analysis page.
